Squadron Capital Management’s Mentari Therapeutics, Inc. Common Stock MTRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-32,500
Closed -$504K – 53
2026
Q2
$504K Buy
+32,500
New +$359K 0.16% 41

Other funds holding MTRI

Squadron Capital Management's MTRI Position: Q3 2026 in Review

Squadron Capital Management sold out of Mentari Therapeutics, Inc. Common Stock (MTRI) in Q3 2026, closing a stake of 32,500 shares — an estimated $504K sold.

Squadron Capital Management first reported a position in MTRI in Q2 2026 and held it in 1 quarter. The position peaked at $504K in Q2 2026. 16 funds tracked by Wall St. Rank hold MTRI as of Q3 2026.

  • Squadron Capital Management reported no remaining Mentari Therapeutics, Inc. Common Stock position as of Q3 2026 after selling out during the quarter.
  • Squadron Capital Management sold 32,500 Mentari Therapeutics, Inc. Common Stock shares in Q3 2026, an estimated $504K.
  • Squadron Capital Management first reported a position in Mentari Therapeutics, Inc. Common Stock in Q2 2026 and held it in 1 quarter.
  • Squadron Capital Management's Mentari Therapeutics, Inc. Common Stock position peaked at $504K in Q2 2026.
  • 16 funds tracked by Wall St. Rank held Mentari Therapeutics, Inc. Common Stock as of Q3 2026.

Based on Squadron Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.